Comparison between long-acting pegylated and daily recombinant human growth hormone for pediatric growth hormone deficiency a systematic review

Abstract This systematic review aims to summarize the therapeutic benefits and safety profile of long-acting PEGylated recombinant human growth hormone (PEG‑rhGH) compared with daily recombinant human growth hormone (DGH) in pediatric growth hormone deficiency (PGHD) participants. We conducted an ex...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Jun Zhang, Song Guo, Tingting Wang, Qiuli Chen
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Subjects:	Long-acting pegylated Recombinant human growth hormone Children Growth hormone deficiency GHD
Online Access:	https://doi.org/10.1038/s41598-025-10613-x